Abstract:Background: Hypopharyngeal carcinoma is characterized by a high degree of malignancy. The most common pathological type is squamous cell carcinoma (HSCC). Cisplatin (cis-diamminedichloroplatinum, CDDP) is one of the most widely used chemotherapeutic drugs nowadays and cisplatin resistance is a major problem in current treatment strategies. Clinical researchers have reported that high autophagy levels often caused insensitivity to chemotherapy, a common phenomenon that greatly reduces the therapeutic effect in cisplatin- resistant tumor cell lines. 3-methyladenine (3-MA), an inhibitor of PI3K, plays a vital role in forming and developing autophagosomes. Therefore, we speculate that the use of 3-MA may reduce cisplatin resistance in hypopharyngeal squamous cell carcinoma (HSCC). Methods: Part I: Cisplatin-resistant FaDu cell line (Human hypopharyngeal squamous cell carcinoma cells) was established and cultured. Cell counting kit-8 was used to detect drug resistance. An inverted microscope was used to observe the morphological changes at different concentrations, then the survival rate was calculated. After MDC staining, the autophagic vacuoles were observed by fluorescence microscopy. The expression of Beclin1 from each group was confirmed by RT-PCR and Western blot method. Part II: 3-MA was applied for cisplatin-resistant cells intervention, Beclin1 was knocked down by plasmid transfection. Cell cycle was detected using flow cytometry assay, apoptosis with necrosis was detected by staining with propidium iodide (PI). CCK-8 was used to observe the cell survival rate in each group. The expression of autophagy-related protein Beclin1, LC3I, LC3II, Atg-5 and P62 in each group was verified by Western blot analysis. Results: Cisplatin-resistant FaDu cell line can be stably constructed by cisplatin intervention. Compared with normal group, autophagy and its related protein Beclin1 expression were enhanced in cisplatin resistant FaDu cells. Autophagy inhibition group showed significant cell cycle changes, mainly manifested by G1 arrest, increased apoptosis rate and significantly decreased survival rate at 24h level. The number of autophagy vacuoles were significantly reduced in the 3-MA group. Furthermore, Western blot showed that expression of Beclin1, lc3-I, lc3-II, atg-5 protein decreased significantly after 3-MA intervention, while the expression of p62 upregulated, which also confirmed autophagy flow was blocked. Conclusion: Our work confirmed that enhanced autophagy is an important cause of cisplatin resistance in FaDu cells. The use of 3-MA can significantly reduce autophagy level and arresting its cell cycle, promote apoptosis and reverse the cisplatin resistance condition, this effect is partly mediated by inhibition of Beclin-1 expression. Our data provide a theoretical basis for the application of 3-MA in overcoming cisplatin resistance in hypopharyngeal cancer.

Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α

The Impact of Hypoxia Improvement on Laryngeal Squamous Cell Carcinoma Chemotherapy

[Cisplatin Enhances Apoptosis in Bladder Cancer Cells Via Autophagy].

SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy

Induction of Autophagy Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells

Inhibition of autophagy enhanced chemosensitivity in cisplatin resistant hypopharyngeal squamous carcinoma cells

Autophagy Inhibitor Chloroquine Increases Sensitivity To Cisplatin In Qbc939 Cholangiocarcinoma Cells By Mitochondrial Ros

Inhibition Of Autophagy Promotes Cisplatin-Induced Apoptotic Cell Death Through Atg5 And Beclin 1 In A549 Human Lung Cancer Cells

Autophagy Facilitates Lung Adenocarcinoma Resistance to Cisplatin Treatment by Activation of AMPK/mTOR Signaling Pathway.

Er Stress and Autophagy Are Involved in the Apoptosis Induced by Cisplatin in Human Lung Cancer Cells

Hypoxia-Induced Autophagy Contributes To The Chemoresistance Of Hepatocellular Carcinoma Cells

Autophagic Flux Promotes Cisplatin Resistance in Human Ovarian Carcinoma Cells Through ATP-mediated Lysosomal Function.

Overcoming Cisplatin Resistance of Ovarian Cancer Cells by Targeting HIF-1-regulated Cancer Metabolism.

Hypoxia-induced PVT1 Promotes Lung Cancer Chemoresistance to Cisplatin by Autophagy Via PVT1/miR-140-3p/ATG5 Axis

Changes and significances of apoptosis and autophagy levels of ovarian cancer sensitive cells-A2780 and resistant cells-A2780/DDP after treated with cisplatin

Inhibition of Autophagy Improves Resistance and Enhances Sensitivity of Gastric Cancer Cells to Cisplatin.

Enhancer-bound Nrf2 licenses HIF-1 transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells

Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells

Inhibition of Autophagy Enhances Cisplatin Cytotoxicity Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells

3-MA Enhanced Chemosensitivity in Cisplatin Resistant Hypopharyngeal Squamous Carcinoma Cells via Inhibiting Beclin -1 Mediated Autophagy

Induction of autophagy by cisplatin‐resistant esophageal cancer cells promotes survival and recovery